• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll 样受体对丙型肝炎病毒感染的反应:最新综述。

Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview.

机构信息

Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal 8210, Bangladesh.

Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.

出版信息

Int J Mol Sci. 2022 May 13;23(10):5475. doi: 10.3390/ijms23105475.

DOI:10.3390/ijms23105475
PMID:35628287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9141274/
Abstract

Hepatitis C virus (HCV) infection remains a major global health burden, causing chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Toll-like receptors (TLRs) are evolutionarily conserved pattern recognition receptors that detect pathogen-associated molecular patterns and activate downstream signaling to induce proinflammatory cytokine and chemokine production. An increasing number of studies have suggested the importance of TLR responses in the outcome of HCV infection. However, the exact role of innate immune responses, including TLR response, in controlling chronic HCV infection remains to be established. A proper understanding of the TLR response in HCV infection is essential for devising new therapeutic approaches against HCV infection. In this review, we discuss the progress made in our understanding of the host innate immune response to HCV infection, with a particular focus on the TLR response. In addition, we discuss the mechanisms adopted by HCV to avoid immune surveillance mediated by TLRs.

摘要

丙型肝炎病毒(HCV)感染仍然是一个重大的全球健康负担,导致慢性肝炎、肝硬化和肝细胞癌。Toll 样受体(TLR)是进化上保守的模式识别受体,可检测病原体相关分子模式,并激活下游信号转导,诱导促炎细胞因子和趋化因子的产生。越来越多的研究表明,TLR 反应在 HCV 感染的结果中很重要。然而,先天免疫反应,包括 TLR 反应,在控制慢性 HCV 感染中的确切作用仍有待确定。正确理解 HCV 感染中的 TLR 反应对于制定针对 HCV 感染的新治疗方法至关重要。在这篇综述中,我们讨论了对 HCV 感染中宿主先天免疫反应的理解进展,特别关注 TLR 反应。此外,我们还讨论了 HCV 采用的逃避 TLR 介导的免疫监视的机制。

相似文献

1
Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview. Toll 样受体对丙型肝炎病毒感染的反应:最新综述。
Int J Mol Sci. 2022 May 13;23(10):5475. doi: 10.3390/ijms23105475.
2
Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview.Toll 样受体对人类免疫缺陷病毒 1 或乙型肝炎或丙型肝炎病毒合并感染的反应:概述。
Int J Mol Sci. 2023 Jun 1;24(11):9624. doi: 10.3390/ijms24119624.
3
Toll-like receptors and hepatitis C virus infection.Toll样受体与丙型肝炎病毒感染
Hepatobiliary Pancreat Dis Int. 2021 Dec;20(6):521-529. doi: 10.1016/j.hbpd.2021.07.011. Epub 2021 Aug 10.
4
Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者对 Toll 样受体配体低反应性与肝功能障碍的相关性。
J Viral Hepat. 2011 Oct;18(10):e561-7. doi: 10.1111/j.1365-2893.2011.01478.x. Epub 2011 May 25.
5
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.HCV 感染的肝细胞中趋化因子和炎症细胞因子反应的激活依赖于 Toll 样受体 3 对 HCV 双链 RNA 中间体的识别。
Hepatology. 2012 Mar;55(3):666-75. doi: 10.1002/hep.24763. Epub 2012 Jan 30.
6
Interaction of Hepatitis C virus proteins with pattern recognition receptors.丙型肝炎病毒蛋白与模式识别受体的相互作用。
Virol J. 2012 Jun 22;9:126. doi: 10.1186/1743-422X-9-126.
7
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.Toll 样受体对乙型肝炎病毒感染的反应及 TLR 激动剂作为治疗慢性乙型肝炎免疫调节剂的潜力:综述。
Int J Mol Sci. 2021 Sep 28;22(19):10462. doi: 10.3390/ijms221910462.
8
Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.丙型肝炎病毒感染:宿主-病毒相互作用和病毒持续存在的机制。
Cells. 2019 Apr 25;8(4):376. doi: 10.3390/cells8040376.
9
Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.慢性丙型肝炎病毒感染时髓样树突状细胞中细胞因子反应受损,与Toll样受体和视黄酸诱导基因-I表达增强无关。
J Med Virol. 2008 Jun;80(6):980-8. doi: 10.1002/jmv.21174.
10
[RIG-I mediated hepatic innate immune signaling that controls HCV infection].[维甲酸诱导基因I(RIG-I)介导的肝脏固有免疫信号传导对丙型肝炎病毒(HCV)感染的控制作用]
Uirusu. 2008 Dec;58(2):105-15. doi: 10.2222/jsv.58.105.

引用本文的文献

1
Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development.基孔肯雅病毒感染中的Toll样受体(TLR)反应:激活机制、免疫逃逸以及TLR激动剂在疫苗开发中的应用
Vaccines (Basel). 2025 Aug 13;13(8):856. doi: 10.3390/vaccines13080856.
2
Association of TLR3 1337C/T and 1234C/T polymorphisms with chronic hepatitis B virus infection in Sudanese patients: A case-control study.苏丹患者中TLR3 1337C/T和1234C/T基因多态性与慢性乙型肝炎病毒感染的关联:一项病例对照研究。
J Int Med Res. 2025 Jul;53(7):3000605251358062. doi: 10.1177/03000605251358062. Epub 2025 Jul 24.
3

本文引用的文献

1
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.TLR 对 SARS-CoV-2 感染反应的最新研究进展概述及 TLR 激动剂作为 SARS-CoV-2 疫苗佐剂的潜力。
Viruses. 2021 Nov 18;13(11):2302. doi: 10.3390/v13112302.
2
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.Toll 样受体对乙型肝炎病毒感染的反应及 TLR 激动剂作为治疗慢性乙型肝炎免疫调节剂的潜力:综述。
Int J Mol Sci. 2021 Sep 28;22(19):10462. doi: 10.3390/ijms221910462.
3
Viral oncogenesis in cancer: from mechanisms to therapeutics.
癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
4
Toll-like receptor response to Zika virus infection: progress toward infection control.Toll样受体对寨卡病毒感染的反应:感染控制方面的进展
Npj Viruses. 2025 Mar 13;3(1):20. doi: 10.1038/s44298-025-00102-3.
5
Discovery of Active Ingredient of Yinchenhao Decoction Targeting TLR4 for Hepatic Inflammatory Diseases Based on Deep Learning Approach.基于深度学习方法发现茵陈蒿汤治疗肝脏炎症性疾病的靶向TLR4活性成分
Interdiscip Sci. 2025 Jun;17(2):293-305. doi: 10.1007/s12539-024-00670-7. Epub 2024 Nov 19.
6
Proteomic analysis of the SMN complex reveals conserved and etiologic connections to the proteostasis network.运动神经元存活蛋白(SMN)复合体的蛋白质组学分析揭示了与蛋白质稳态网络的保守联系及病因学关联。
Front RNA Res. 2024;2. doi: 10.3389/frnar.2024.1448194. Epub 2024 Sep 17.
7
Chaperoning the chaperones: Proteomic analysis of the SMN complex reveals conserved and etiologic connections to the proteostasis network.陪伴分子伴侣:SMN复合物的蛋白质组学分析揭示了与蛋白质稳态网络的保守联系和病因学关联。
bioRxiv. 2024 May 16:2024.05.15.594402. doi: 10.1101/2024.05.15.594402.
8
Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection.近期对 Toll 样受体(TLR)响应流感病毒感染的分子机制的深入了解。
Int J Mol Sci. 2024 May 29;25(11):5909. doi: 10.3390/ijms25115909.
9
TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.Toll样受体激动剂作为预防病毒感染的疫苗佐剂:概述
Front Microbiol. 2023 Dec 21;14:1249718. doi: 10.3389/fmicb.2023.1249718. eCollection 2023.
10
Meta-analysis of the association between toll-like receptor gene polymorphisms and hepatitis C virus infection.Toll样受体基因多态性与丙型肝炎病毒感染之间关联的荟萃分析。
Front Microbiol. 2023 Oct 5;14:1254805. doi: 10.3389/fmicb.2023.1254805. eCollection 2023.
Tree Shrew as an Emerging Small Animal Model for Human Viral Infection: A Recent Overview.
树鼩作为一种新兴的人类病毒感染小动物模型:最新综述。
Viruses. 2021 Aug 18;13(8):1641. doi: 10.3390/v13081641.
4
Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword.血小板先天免疫受体和 TLRs:一把双刃剑。
Int J Mol Sci. 2021 Jul 23;22(15):7894. doi: 10.3390/ijms22157894.
5
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.Toll样受体2(TLR2)可识别严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的包膜蛋白以产生炎性细胞因子。
Nat Immunol. 2021 Jul;22(7):829-838. doi: 10.1038/s41590-021-00937-x. Epub 2021 May 7.
6
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection.Toll样受体激动剂作为训练有素的免疫的介质:对抗感染的机制洞察和免疫治疗潜力
Front Immunol. 2021 Feb 18;11:622614. doi: 10.3389/fimmu.2020.622614. eCollection 2020.
7
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.预防性鼻腔内给予 TLR2/6 激动剂可减少 SARS-CoV-2 挑战雪貂模型的上呼吸道病毒脱落。
EBioMedicine. 2021 Jan;63:103153. doi: 10.1016/j.ebiom.2020.103153. Epub 2020 Dec 3.
8
Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers.埃及医护人员 Toll 样受体(TLR)-3 和 TLR-9 基因多态性与丙型肝炎病毒特异性细胞免疫结果的关系。
Clin Exp Immunol. 2021 Jan;203(1):3-12. doi: 10.1111/cei.13514. Epub 2020 Oct 2.
9
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.咪喹莫特 - 一种 Toll 样受体 7 激动剂 - 是治疗 COVID-19 的理想选择。
Environ Res. 2020 Sep;188:109858. doi: 10.1016/j.envres.2020.109858. Epub 2020 Jun 23.
10
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies.Toll 样受体激动剂在 HIV-1 治愈策略中的应用。
Front Immunol. 2020 Jun 11;11:1112. doi: 10.3389/fimmu.2020.01112. eCollection 2020.